Related Experiment Video
Updated: Apr 2, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Maternal bile acid transporter deficiency promotes neonatal demise
Yuanyuan Zhang1, Fei Li2, Yao Wang1
1Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, USA.
Insights
Maternal cholestasis during pregnancy causes neonatal death by affecting lung development. Targeting pulmonary bile acids may improve neonatal survival in cases of intrahepatic cholestasis of pregnancy (ICP).
Area of Science:
- Reproductive biology
- Neonatal physiology
- Hepatology
Background:
- Intrahepatic cholestasis of pregnancy (ICP) affects 0.4-5% of pregnancies globally, leading to adverse neonatal outcomes.
- Neonatal mortality is a significant concern in ICP, necessitating research into underlying mechanisms.
Purpose of the Study:
- To investigate the mechanisms by which maternal cholestasis leads to neonatal death.
- To identify potential therapeutic targets for improving neonatal survival in ICP.
Main Methods:
- Utilized a mouse model with Abcb11 deficiency to induce maternal cholestasis.
- Analyzed pulmonary bile acid levels and surfactant structure in neonates.
- Investigated the effect of Nr1i2 deficiency in combination with Abcb11 deficiency.
Main Results:
- Maternal cholestasis (Abcb11 deficiency) caused neonatal death within 24 hours due to pulmonary hypoxia and atelectasis.
- Neonates exhibited elevated pulmonary bile acids and disrupted pulmonary surfactant structure.
- Co-deficiency of Abcb11 and Nr1i2 reduced maternal bile acids and improved neonatal survival.
Conclusions:
- Pulmonary bile acids are identified as a key factor disrupting pulmonary surfactant structure in neonates of ICP.
- Findings suggest therapeutic interventions targeting pulmonary bile acids could ameliorate neonatal respiratory failure in ICP.
- This study provides critical insights into the pathophysiology of neonatal respiratory distress associated with elevated maternal bile acids.
Abstract:
Intrahepatic cholestasis of pregnancy (ICP) is associated with adverse neonatal survival and is estimated to impact between 0.4 and 5% of pregnancies worldwide. Here we show that maternal cholestasis (due to Abcb11 deficiency) produces neonatal death among all offspring within 24 h of birth due to atelectasis-producing pulmonary hypoxia, which recapitulates the neonatal respiratory distress of human ICP. Neonates of Abcb11-deficient mothers have elevated pulmonary bile acids and altered pulmonary surfactant structure. Maternal absence of Nr1i2 superimposed on Abcb11 deficiency strongly reduces maternal serum bile acid concentrations and increases neonatal survival. We identify pulmonary bile acids as a key factor in the disruption of the structure of pulmonary surfactant in neonates of ICP. These findings have important implications for neonatal respiratory failure, especially when maternal bile acids are elevated during pregnancy, and highlight potential pathways and targets amenable to therapeutic intervention to ameliorate this condition.
Related Concept Videos
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Pharmacokinetics in Pediatric Patients: Drug Metabolism

